Chronic lymphocytic leukaemia trials in United States

In United States 186 Also abroad 309

186 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Where
Boston
Age
18 years and over
People
80
Run by
Dana-Farber Cancer Institute
See details and how to joinNCT07426484
Phase 2Not yet taking people in United States
Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors
Where
Chapel Hill
Age
18 years and over
People
45
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07526597
Phase 1Taking people
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
Where
Chapel Hill, Cincinnati, Columbus, Dallas, Louisville
Age
18 years and over
People
84
Run by
Lomond Therapeutics Holdings, Inc.
See details and how to joinNCT06708897
No phaseNot yet taking people in United States
Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
Where
Duarte, San Diego, Stanford
Age
18 years and over
People
500
Run by
Tina Baykaner
See details and how to joinNCT07711327
Phase 2Not yet taking people in United States
Nemtabrutinib With Venetoclax and Obinutuzumab in Patients With Chronic Lymphocytic Leukemia
Where
Milwaukee
Age
18 years and over
People
30
Run by
Medical College of Wisconsin
See details and how to joinNCT07690891
No phaseTaking people
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Where
Akron, Amarillo, Ann Arbor, Atlanta, Augusta, Aurora, Baltimore, Beech Grove, Bethesda, Birmingham, Boston, Brandywine, Buffalo, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Denver, Detroit, Duarte, Durham, Fort Sam Houston, Fort Worth, Gainesville, Gilbert, Glendale, Grand Rapids, Hackensack, Hershey, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, La Jolla, Lake Sucess, Little Rock, Loma Linda, Los Angeles, Louisville, Lubbock, Madison, Maywood, Memphis, Miami, Milwaukee, Morgantown, Nashville, New Brunswick, New Haven, New Hyde, New Orleans, New York, Oakland, Oklahoma City, Omaha, Orange, Orlando, Park Ridge, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Richmond, Rochester, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Seattle, Sioux Falls, Stanford, St Louis, Stony Brook, St. Petersburg, Tampa, The Bronx, Tucson, Washington D.C., Westwood, Winston-Salem, Worcester, Zion
People
99,999
Run by
Center for International Blood and Marrow Transplant Research
See details and how to joinNCT01351545
No phaseTaking people
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Where
Atlanta
Age
18 years and over
People
200
Run by
Emory University
See details and how to joinNCT03501576
Phase 2Taking people
Allo HSCT Using RIC and PTCy for Hematological Diseases
Where
Minneapolis
Age
Up to 75 years
People
56
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT05805605
Phase 1Taking people
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Where
Atlanta, Bethesda, Chicago, Cincinnati, Cleveland, Denver, Duarte, Durham, Houston, Ithaca, Miami, Milwaukee, New Haven, New York, Philadelphia, Salt Lake City, San Francisco, Sarasota
Age
18 years and over
People
572 worldwide
Run by
Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00
No phaseTaking people
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Where
Chapel Hill
Age
18 years and over
People
40
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT06860880
Phase 1Not yet taking people in United States
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies
Where
Cleveland
Age
18 years to 75 years
People
27
Run by
Luminary Therapeutics
See details and how to joinNCT07679919
Phase 2Not yet taking people in United States
A Phase 2 Trial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic Leukemia
Where
Houston
Age
18 years and over
People
40
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT07674810
No phaseTaking people
Registry of Older Patients With Cancer
Where
Boone, Chapel Hill, Greenville, Hendersonville, Morehead City, New Bern, Raleigh
Age
65 years and over
People
3,000
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137825
Phase 2Taking people
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Where
Duarte
Age
18 years to 80 years
People
35
Run by
City of Hope Medical Center
See details and how to joinNCT06815003
Phase 2Taking people
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Where
Minneapolis
Age
Up to 60 years
People
300
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT03314974
Phase 1/2Taking people
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
Where
Seattle
Age
18 years to 75 years
People
75
Run by
Fred Hutchinson Cancer Center
See details and how to joinNCT03128034
Phase 1/2Taking people
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
Where
Seattle
Age
18 years to 75 years
People
30
Run by
Fred Hutchinson Cancer Center
See details and how to joinNCT03670966
Phase 3Taking people
Global Trial in APG2575 for Patients With CLL/SLL
Where
Anaheim, Ann Arbor, Boston, Greenville, Houston, Jacksonville, Kingswood, Miami Beach, Peoria, Richmond, Tuscon
Age
18 years to 99 years
People
400 worldwide
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT06104566 · EU 2023-508005-24-00
Phase 2Taking people
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
Where
Columbus, Dallas, Florham Park, Miami Beach, Pittsburgh, Rochester
Age
18 years and over
People
108 worldwide
Run by
Curis, Inc.
See details and how to joinNCT07271667 · EU 2025-523600-68-00
No phaseTaking people
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
Where
Rochester
Age
18 years and over
People
400
Run by
University of Rochester NCORP Research Base
See details and how to joinNCT07638007
Phase 1Taking people
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
Where
Rochester
Age
18 years and over
People
25
Run by
Mayo Clinic
See details and how to joinNCT04892277
Phase 2Taking people
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
Where
Gainesville
Age
6 months to 39 years
People
20
Run by
University of Florida
See details and how to joinNCT05800210
Phase 2Taking people
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Where
Seattle
Age
6 months and over
People
60
Run by
Fred Hutchinson Cancer Center
See details and how to joinNCT04195633
Phase 1Taking people
Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies
Where
Columbus
Age
2 years and over
People
54
Run by
Sumithira Vasu
See details and how to joinNCT05418088
Phase 1Taking people
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
Where
Boston
Age
18 years and over
People
15
Run by
Dana-Farber Cancer Institute
See details and how to joinNCT03219450